DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS DETERMINATION OF PARITAPREVIR, RITONAVIR AND OMBITASVIR IN FIXED TABLET DOSAGE FORM

Journal Title: Indo American Journal of Pharmaceutical Research - Year 2018, Vol 8, Issue

Abstract

Developing a single analytical method for the estimation of individual drugs is very challenging, due to the formation of drug-drug and drug-excipient interactions. The present study demonstrates the applicability of thechromatographic method to develop a new, sensitive, single HPLC method for the simultaneous quantitative determination of three antiviral agents in thefixed pharmaceutical dosage form. Chromatographic separation of the three antiviral drugs was achieved by using a gradient elution at a flow rate of 1.5 mL/min on Inertsil ODS 3V C18 column (250m×4.6mm, 5μm particle size, 100Å pore size) at ambient temperature. Mobile phase A of the gradient solvent system was KH2PO4 (0.03M) in 1000 ml of water and by adjusting the pH to 3.2 with dilute ortho-phosphoric acid and mobile phase B was Methanol and water in the ratio of 85:15 v/v. UV detection at 265 nm was employed to monitor the analytes. A linear response was observed for Paritaprevir over the concentration range 30–90 μg/ mL, 20-60 μg/ mLof Ritonavir and5-15μg/ mL of Ombitasvir.

Authors and Affiliations

Keywords

Related Articles

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND N-ACETYLCYSTINE IN ITS BULK AND EFFERVESCENT TABLET DOSAGE FORM

Abstract The present study describes a simple, accurate, precise and cost effective Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method for simultaneous estimation of Paracetamol and N-Acetylcysteine in...

A REVIEW OF ANALYTICAL PERSPECTIVES OF LINAGLIPTIN

Abstract Linagliptin is an oral anti-diabetic drug belong to the class of dipeptidyl peptidase -4 (DPP-4 inhibitors).It is widely used in the treatment of type –II diabetes mellitus which is characterized by insulin resi...

DEVELOPMENT OF ASSAY METHOD AND FORCED DEGRADATION STUDY OF LEDIPASVIR AND SOFOSBUVIR BY RP-HPLC IN TABLET FORMULATION

Abstract Chronic hepatitis C virus (HCV) infection is one of the most common etiologies of liver-related mortality throughout the world. Sofosbuvir and ledipasvir are inhobits HCV NS5B and HCV NS5A polymerase respectivel...

Optimization of fast dissolving aceclofenac tablets using factorial design

The Aceclofenac is available in tablets dosage form and is yet not official in any pharmacopoeia except B.P. Aceclofenac is practically insoluble in water and peak blood level rechease between 1.25 to 3 hrs after oral ad...

FORMULATION AND EVALUATION OF GASTRO-RETENTIVE FLOATING TABLETS OF ATENOLOL

Abstract The purpose of the present study was to develop gastro-retentive floating tablet of Atenolol. It is a beta-adrenoreceptor antagonist (beta-blocker) used in the treatment of hypertension and angina pectoris. It i...

Download PDF file
  • EP ID EP490218
  • DOI -
  • Views 109
  • Downloads 0

How To Cite

(2018). DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS DETERMINATION OF PARITAPREVIR, RITONAVIR AND OMBITASVIR IN FIXED TABLET DOSAGE FORM. Indo American Journal of Pharmaceutical Research, 8(), 1165-1173. https://europub.co.uk./articles/-A-490218